Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)
about
Efficacy and safety of mineralocorticoid receptor antagonists for patients with heart failure and diabetes mellitus: a systematic review and meta-analysisNovel insight into the dangerous connection between diabetes and heart failure.Underutilization of Aldosterone Antagonists in Heart Failure.Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure.Lessons learned in acute heart failure.
P2860
Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@ast
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@en
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@nl
type
label
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@ast
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@en
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@nl
prefLabel
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@ast
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@en
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@nl
P2093
P2860
P50
P1476
Mineralocorticoid receptor ant ...... litus (from the EVEREST Trial)
@en
P2093
EVEREST Trial Investigators
Haris P Subacius
Marvin A Konstam
Robert J Mentz
Sadiya Khan
Stephen J Greene
P2860
P304
P356
10.1016/J.AMJCARD.2014.05.064
P407
P50
P577
2014-06-24T00:00:00Z